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ABSTRACT: This paper describes the use of magnetic levitation (MagLev) to measure the association of proteins and ligands. The 
method starts with diamagnetic gel beads that are functionalized with covalently bound small molecules (putative ligands).  Binding 
of protein to the ligands within the bead causes a change in the density of the bead. When these beads are suspended in a paramag-
netic aqueous buffer and placed between the poles of two NbFeB magnets with like poles facing, the changes in the density of the 
bead result in predictable and measurable changes in the levitation height of the bead. This paper uses a reaction-diffusion model to 
examine the physical principles that determine the values of rate and equilibrium constants measured by this system, using the well-
defined model system of carbonic anhydrase and aryl sulfonamides. By tuning the experimental protocol, the method is capable of 
quantifying either the concentration of protein in a solution, or the binding affinities of a protein to several resin-bound small mole-
cules simultaneously. Since this method requires no electricity and only a single piece of inexpensive equipment, it may find use in 
situations where portability and low cost are important, such as in bioanalysis in resource-limited settings, point-of-care diagnosis, 
veterinary medicine, and plant pathology.  
INTRODUCTION 
Bioassays that involve the binding of proteins to resin-bound 
small molecules are often used to screen for inhibitors of pro-
teins, and to identify cellular targets of bioactive small mole-
cules.
1 On-bead binding assays are also used to determine the 
concentrations of specific proteins in solutions.
2 Current meth-
ods for on-bead binding assays often use fluorescent or radio-
active labels to quantify the binding of a receptor to its ligand.
3 
The installation and measurement of these labels often requires 
access to relatively expensive equipment and materials. While 
these methods are very broadly useful, we believe that a low-
cost, label-free alternative would be valuable for many appli-
cations (for example, in point-of-care diagnosis, especially in 
resource-limited environments).
4 
This article describes a method for measuring the associa-
tion of proteins and ligands that uses magnetic levitation 
(MagLev).
5 The method employs porous diamagnetic beads 
that are functionalized with covalently bound small molecules 
(putative ligands).  We suspend these diamagnetic beads in a 
paramagnetic aqueous solution, which is placed in a cuvette 
between two permanent NdFeB magnets oriented with like 
poles facing each other (Figure 1).  The balance of gravitation-
al and magnetic forces acting on the diamagnetic bead causes 
beads within a range of densities to levitate; the density of the 
bead determines the equilibrium position of the bead in the 
magnetic field.
6 With an appropriate choice of bead, binding 
of protein to ligands within the bead causes a change in the 
overall density of the bead, and results in a change in the posi-
tion at which it levitates.
6a 
 
 
Figure 1. Schematic representation of the device and method 
based on MagLev for detecting proteins binding to small mole-
cules immobilized a diamagnetic bead.  The device consists of 
two 0.4 T NdFeB magnets oriented with like poles facing each 
other.  A diamagnetic bead suspended in a paramagnetic solution 
levitates in the presence of the magnetic field when the gravita-
tional force (Fg) acting on the bead is balanced by the magnetic 
force (Fm).  Binding of protein to the bead alters its vertical posi-
tion within the device. 
This analytical method has the potential to be very simple 
operationally. The underlying physical chemistry is, however, 
more complicated: it requires partitioning of protein from solu-
tion into the bead, diffusion of protein within the bead, and 
binding of the protein to the immobilized ligands.
7 To examine 2 
 
the fundamental principles that determine rates and equilibri-
um constants as measured by this system, we have developed a 
model that enables us to explore all of these characteristics. 
This model generates data in the form of density of the bead as 
a function of time. We use this model to define the range of 
physical parameters (e.g., concentration of protein, dissocia-
tion constant of the protein-ligand complex) over which we 
expect the assay to work. Detailed experimental work using a 
model system supports the validity of this analysis and leads to 
predictions about how the system may be improved. 
The objective of this paper is to summarize a physical-
organic study of a MagLev-based analytical tool for detecting 
protein and analyzing protein-ligand interactions, rather than 
to prove the generality and limits of this method in practical 
analysis. This study is thus aimed at defining the characteris-
tics of the system, and building an analytical model for it, with 
the goal of constructing the physical-chemical foundation for 
future use in bioanalysis.  
Our model system consists of poly[acryloylated O,O’-bis(2-
aminopropyl) polyethylene glycol] (PEGA) beads that are 
covalently labeled with known inhibitors of bovine carbonic 
anhydrase (BCA; E.C. 4.2.1.1). We levitate these beads in 
solutions of BCA and monitor the change in levitation height – 
and hence the change in density of the beads – over time, as 
protein binds to the beads. We explain the observed kinetics 
using a reaction-diffusion model, and validate this model by 
using it to explain the effects of varying several experimental 
parameters (the concentration of protein, the concentration of 
immobilized ligand, the protein-ligand binding constant, and 
the size of the beads) on the rate of protein binding to the 
beads and the total amount of protein that binds to the beads. 
This Maglev-based technique has six attributes that make it 
an attractive approach for detecting protein-ligand binding 
events: (i) It is inexpensive (requiring only a capillary tube or 
a cuvette filled with a paramagnetic solutions, and two NdFeB 
magnets that cost ~$5 – 20 each). (ii) It is easy to use: the re-
sults can be visualized with the unaided eye. (iii) It is sensi-
tive: association or dissociation of pmoles of protein to or from 
an appropriate bead results in an easily measurable change in 
its levitation height. (iv) It is quantitative: with the correct 
orientation and separation of magnets, the amount of protein 
bound per bead correlates linearly with the levitation height of 
the bead. (v) It can be multiplexed, and offers a method for 
comparing binding constants of different ligands. (vi) It ena-
bles monitoring of association and dissociation of proteins to 
and from beads in real time.  
The technique, however, has at least five characteristics that 
are either of uncertain value, or are limitations: (i) The detec-
tion is carried out in non-physiological medium containing a 
non-natural ion at moderate ionic strength (e.g., 300 mM che-
lated gadolinium, 6 mM phosphate,  pH 7.4).
8 (ii) The assay 
requires at least one ligand (with Kd < 1 mM) that can be at-
tached covalently to the diamagnetic bead. (iii) The bead must 
be different in density from the protein, so that the association 
of protein and ligand in the bead results in a change in the 
average density of the bead.  (iv) Mass transport (i.e., diffu-
sion) of protein through the gel-based bead is rate-limiting; 
measurement of protein-ligand on and off rates is, therefore, 
not possible. (v) The effective pore size of the gel must be 
sufficiently large to allow protein in solution to partition into 
the bead to a concentration that produces a perceptible change 
in density. 
Other techniques may also be used to detect protein binding 
to solid supports directly (e.g., quartz microbalances
9, cantile-
vers
10, force transduction
11, conductance modification
12, sur-
face plasmon resonance
13 and other optical methods). These 
techniques, however, certainly require electricity, and also 
often require sophisticated laboratory equipment. We believe 
that using MagLev to monitor protein-ligand binding may, 
after further development, find use in several clinical situa-
tions, including: (i) in the developing world, where access to 
electricity is not guaranteed, (ii) in point-of-care settings, 
where a small and simple solution is desirable, and (iii) in ap-
plications for other in-the-field settings where simplicity may 
be important (e.g., veterinary or plant pathology, forensics, 
food quality, and other types of chemical analysis). MagLev-
based binding assays may also find use in protein-ligand bind-
ing assays in drug development and biochemistry, where resin-
bound small molecules are often used to identify inhibitors of 
proteins, or as a research tool to aid in identifying the cellular 
targets of small molecules. 
 
EXPERIMENTAL DESIGN 
Design of the Device. We used a device we described pre-
viously; it consists of two commercial NdFeB magnets (50  
50  25 mm) positioned with like poles facing towards each 
other, 45 mm apart.
6  In this configuration of magnets, Eqn. 1 
describes the vertical position of the levitating bead (h), and 
indicates that the position correlates linearly with the density 
of the bead (ρbead).   
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In this equation, ρbead and ρm, (both kg·m
-3) and χbead and χm 
(both unitless) are the densities and the magnetic susceptibili-
ties of the bead and the paramagnetic medium, respectively; g 
is the acceleration due to gravity (m·s
-2), μ0 is the magnetic 
permeability of free space (N·A
-2), d is the distance between 
the magnets (m), and B0 is the magnitude of the magnetic field 
at the surface of the magnets (T). 
Choice of the Paramagnetic Fluid. We chose to use buff-
ered aqueous solutions of disodium gadolinium (III) diethy-
lenetriaminepentaacetic acid (2Na
+·Gd(DTPA)
2–) as the medi-
um for levitation.  Gd(DTPA) is a relatively low-cost ($3/g), 
commercially available, water-soluble MRI contrast agent 
with high magnetic susceptibility. The complex is non-
denaturing, and has a stability constant of 10
17.7 M
-1 in aqueous 
solutions at pH 7.4.
14,15 Adjusting the concentration of the par-
amagnetic ion tunes the dynamic range and sensitivity of the 
assay. Higher concentrations of the paramagnetic ion increase 
the dynamic range of the assay; lower concentrations increase 
the sensitivity.
6c The absolute range can also be adjusted by 
addition of a diamagnetic material with higher or lower densi-
ty (e.g., sucrose or ethanol, respectively).
6c 
The experiments described in this paper can be conveniently 
performed in 300-mM solutions of Gd(DTPA) in phosphate-
buffered saline (1100 mOsm·kg
-1, see Supporting Infor-
mation). We quantified the magnetic susceptibility (χbead – χm  
χm = 8.400·10
-5) and density (ρm = 1.099 g·mL
-1) of this levita-
tion buffer using density standard beads (see Supporting In-
formation).
6c We used two magnets separated by 45 mm in an 
anti-Helmholtz configuration. In this configuration the mag-3 
 
netic field strength was 0.38 T at the surface of the magnets; 
this value provided a dynamic range in density of 1.056 – 
1.143 g·mL
-1. 
We used a ruler with a millimeter scale to measure the dis-
tance from the bottom magnet to a levitating bead (i.e., the 
levitation height of the bead). Using a digital camera outfitted 
with a macro lens, we could measure this distance with an 
uncertainty of ±0.1 mm; measuring the levitation height with 
the unaided eye increased this uncertainty to ±0.3 mm. The 
greatest source of uncertainty in calculating the density of a 
bead from the levitation height of that bead is the measurement 
of its levitation height. Using a camera, we could, therefore, 
measure the change in density of a bead with an uncertainty of 
±0.0002 g·cm
-3; without the camera the uncertainty increased 
to ±0.0006 g·cm
-3. 
Choice of Model Protein-Ligand System. We defined the 
basic biophysical chemistry of protein binding using bovine 
carbonic anhydrase (BCA) as a model system
16 because: (i) 
BCA is inexpensive and commercially available. (ii) Numer-
ous inhibitors of BCA are known; many are commercially 
available and have well-characterized binding constants. Many 
inhibitors of CA contain aryl sulfonamides, which bind to the 
active site Zn(II) ion as anionic ligands, and several of the 
reported inhibitors can be covalently attached to the polymer 
support using standard coupling chemistry. (iii) BCA is a 
small protein (~ 30 kDa) and will diffuse in and out of the 
PEGA beads (vide supra) used in this study. (iv) BCA has a 
very stable tertiary structure, and is not adversely affected by 
the levitation media. (v) There is extensive background on the 
use of carbonic anhydrase in physical organic studies of pro-
tein binding. In particular values of Kd, kon, and koff, are known 
for a number of ligands.  
Choice of Solid Support (Resin). We used commercially 
available poly[acryloylated O,O’-bis(2-aminopropyl) polyeth-
ylene glycol] (PEGA) beads for this study (300-500 µm diam-
eter in water).
17 This resin is synthesized from 1900 MW PEG. 
These beads present amine functionality (0.2 mmol·g
-1); this 
functional group makes chemical modification straightfor-
ward. In addition, previous studies have demonstrated that 
PEGA beads resist non-specific adsorption of proteins.
18-21 
This combination of properties has resulted in their widespread 
use for applications including: the identification of target pro-
teins of resin-bound small molecules;
18 the screening of librar-
ies of inhibitors;
19 the synthesis of peptides;
20 and the covalent 
immobilization of proteins.
21 
The density of PEGA beads (ρPEGA ≈ 1.07 g·cm
-3) is signifi-
cantly different from the density of the protein (ρprotein ≈ 1.3–
1.5 g·cm
-3).
22 This difference in density is required if binding 
of protein to the bead is to cause a usefully quantifiable change 
in the overall density of the bead.
23  
The main disadvantage of these commercial PEGA beads is 
that their small pores (as a cross-linked acrylamide gel) slow 
the mass transport of proteins into and through the interior of 
the bead, and excludes proteins with molecular weight greater 
than ~ 40-70 kDa.
24 We used fluorescein-labeled BCA (FITC-
BCA) to estimate both the diffusion coefficient of BCA in 
PEGA beads (Dbead  ~ 5 x 10
-13 m
2·s
-1) and the partition coeffi-
cient of BCA between the beads and solution (Kbead/sol  ~ 0.4, 
see the supporting information). This value for the diffusion 
coefficient of BCA within the bead agrees well with data from 
the literature,
25 and is approximately two orders of magnitude 
slower than the diffusion coefficient in water (~ 9 x 10
-11 
m
2·s
-1).
26 
Unmodified PEGA beads are also difficult to visualize dur-
ing levitation because their refractive index is close to that of 
the solution. To improve the visibility of these beads, we func-
tionalized a small portion of the amines on them with dyes 
(e.g., by reaction with the isothiocyanates of rhodamine, mala-
chite green, and 7-dimethylamino-4-methylcoumarin). These 
modifications make the beads easily visible under ambient or 
UV light. 
Model for Quantifying the Amount of Protein Bound 
Per Bead with MagLev. Using Eqn. 1, we derived Eqn. 2 to 
correlate changes in the amount of protein bound to the beads 
and changes in the levitation height of the bead (Δh, m). 
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The change in density, ρbead,p - ρbead, is proportional to the 
difference in the amount of protein present in the bead, after 
displacing an equivalent volume of the buffer solution out of 
the bead (Eqn. 3). Here, [P] is the concentration of protein 
within the bead (M), MWprotein (g·mol
-1) and Vprotein (m
3) are the 
molecular weight and volume of a protein molecule, NA (mol
-1) 
is the Avogadro constant, and ρsol (kg·m
-3) is the density of the 
solution. Using this relationship, ∆h can be expressed linearly 
in terms of [P] (Eqn. 4).  
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BCA has a molecular weight of 29.1 kg·mol
-1 and a volume 
of 3 × 10
-26 m
3 (the protein is assumed to be a sphere with 
radius ~ 20 Å).
27 Eqn. 4, therefore, predicts that, under our 
standard levitation conditions, a 1-mM increase in the concen-
tration of protein within a bead will result in a 5-mm decrease 
in levitation height. Experimentally, we obtained a similar 
value (Δh/[P] = -8.6 mm/mM, see Supporting Information); 
the difference between these experimental and theoretical val-
ues is likely due to inaccuracies in the volume of the protein, 
Vprotein, and/or measurements of the volume of the beads. 
Model for Kinetic Analysis of Binding. MagLev enables 
the detection of a change in density that occurs when a soluble 
protein associates with or dissociates from a ligand that is co-
valently immobilized on a gel or solid support (provided that 
there is a difference in density between the protein and the 
gel/solid support). We model the binding of protein to ligands 
immobilized in a gel matrix by a three step process (Figure 
2A): (i) partitioning of the protein from solution to the gel 
(thereby displacing an equivalent volume of buffer solution 
from the bead into the bulk solution), (ii) diffusion of protein 
within the gel, (iii) binding and unbinding of protein to the 
ligands immobilized in the gel.  
Before each experiment, the gel beads are first equilibrated 
with a buffered solution of Gd(DTPA). Using a magnetic sus-
ceptibility balance, we found that the magnetic susceptibility 
of these equilibrated beads is similar to the magnetic suscepti-
bility of the buffer; this observation indicates that the concen-
tration of Gd(DTPA) in solution is approximately the same 
both inside and outside the bead (see Supporting Information). 
At the beginning of each experiment (t = 0), the beads are 4 
 
transferred to a solution of protein dissolved in the same 
Gd(DTPA) buffer. The process that follows, involving protein 
diffusing into the beads and binding to the ligands immobi-
lized there, can be described mathematically as follows. 
The partitioning of the protein between the bead and the so-
lution is described by the partition coefficient, Kbead/sol (Eqn. 
5), where 
ext
bead P] [  denotes the concentration of proteins at the 
external boundary of the bead and [P]sol denotes the concentra-
tion of protein in the bulk solution. Once inside the bead, the 
protein, Pbead, diffuses toward the center of the bead, reacting 
with the immobilized ligands, *L, to form protein-ligand com-
plexes, *PL, according to Eqn. 6 (throughout this text, * is 
used to indicate a species immobilized on the gel). 
sol
ext
bead sol bead P P K ] /[ ] [ /   (5) 
Pbead + *L   *PL (6) 
 
Figure 2. Reaction-diffusion model describing the binding of 
protein from solution to ligands immobilized in a gel bead. (A) 
The model consists of three distinct steps: (i) partitioning of the 
protein into the bead, (ii) diffusion within the bead, and (iii) bind-
ing of protein to the ligand immobilized on the bead. (B) In a 
diffusion-limited process (fast/instantaneous reaction), reaction 
only occurs at the propagating front, lF, when the flux of protein 
(before the front) encounters the unconsumed ligands at the front. 
This approximation of the diffusion-limited process allows us to 
derive a simplified characteristic time, τ, for the reaction-diffusion 
process.  
Together, the dynamics of all these three steps can be ex-
pressed mathematically in terms of a system of reaction-
diffusion equations (Eqns. 7, 8).
28 In these equations, r is the 
radial coordinate of the bead, t is time, and Dbead is the diffu-
sion coefficient of the protein in the bead. 
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The initial parameters (at t = 0) are defined as follows: (i) 
The concentration of ligand within the bead, [*L], is defined as 
[*L]0. (ii) The concentration of protein in solution ([P]sol) is 
equal to [P]0,sol. (iii) There is no protein within the bead 
([P]bead = 0). (iv) At the external boundary of the bead, the 
concentration of protein is described by the partition coeffi-
cient and the concentration of protein in solution (Eqn. 9). 
sol sol bead
ext
bead P K P , 0 / ] [ ] [   (9) 
The volume of the bead is assumed to be constant, and 
therefore that [*PL] = [*L]0 – [*L].
29 Eqn. 10 describes the 
process of penetration of protein into the bead at its external 
boundary. In this equation, A is the surface area of the bead, r 
is the radial coordinate, Vsol is the volume of solution and NB is 
the number of beads used. 
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In analogy to our experiments, we used the following pa-
rameters for our calculations: (i) The radius of each bead, R, is 
170 μm. (ii) There are 15 beads in each experiment (NB). (iii) 
The volume of the solution, Vsol, is 0.6 mL. (iv) The initial 
concentration of ligand within the bead, [*L]0 is 3.2 mM. (v) 
The partition coefficient, Kbead/sol, is 0.4. (vi) The diffusion 
coefficient, Dbead, is ~10
-12 m
2·s
-1, as observed in a previous 
study and confirmed experimentally by us (see Supporting 
Information).
25 Solving this system of equations using finite-
difference method
30 in spherical coordinates (implemented in 
Matlab), gives the concentration profiles of protein, ligand and 
bound protein-ligand complex with respect to both space and 
time. Integrating the concentration profile of bound protein-
ligand throughout the bead gives the total amount of protein-
ligand complex in the bead, nPL (Eqn. 11).
31  
dr r PL n
R
PL
2
0 ] * [ 4     (11) 
Experimentally, we have determined that the change in levi-
tation height, ∆h (mm), is proportional to nPL (mmol) and in-
versely proportional to the volume of the bead, Vbead (L) ac-
cording to the relationship Δh = -8.6nPL/Vbead (see Supporting 
Information; Eqn. 4 provides a theoretical approximation of 
this relationship). 
The Characteristic Time, τ, of the Reaction-Diffusion 
Process. We describe here our derivation of a characteristic 
time parameter, τ, which describes the time required for the 
reaction-diffusion process to reach equilibrium; we begin by 
proving that this process is diffusion-limited. Eqn. 12 de-
scribes the characteristic time for the binding of protein to 
ligands within a bead, τrxn. In this expression, kon (M
-1s
-1) is the 
reaction rate constant and [P]bead is a characteristic concentra-5 
 
tion of protein in the bead; this concentration can be represent-
ed by the product of the partition coefficient, Kbead/sol, and the 
initial concentration of protein in the solution, [P]0,sol. Based 
on the known values of kon (~ 10
5 M
-1s
-1)
16, Kbead/sol (0.4), and 
[P]0,sol (~100 μM), the characteristic time (τrxn) for the forward 
reaction is, therefore, ~ 0.25 s. Eqn. 13 describes the character-
istic time for diffusion of the protein within the bead (τdiff). 
sol sol bead on bead on
rxn P K k P k , 0 / ] [
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~
] [
1
~   (12)   
bead diff D R / ~
2   (13) 
Given the diffusion coefficient of the protein in the bead, 
Dbead ~ 10
-12 m
2·s
-1, and a bead of radius R (~170 μm), we esti-
mate τdiff to be on the order of 8 hours. Since τdiff >> τrxn (8 hrs 
>> 0.25 s), the reaction-diffusion process is diffusion-limited. 
We, therefore, make the following two assumptions in order to 
derive a simple, analytical expression for the characteristic 
time of the reaction-diffusion process: (i) the reaction to form 
the protein-ligand complex is instantaneous in comparison to 
the rate of diffusion, and (ii) once formed, the protein-ligand 
complex, *PL, does not dissociate (the rate of dissociation is 
typically much slower than the rate of association). Given 
these assumptions, there exists a propagation front of the pro-
tein (Figure 2B), that is a boundary where the concentration of 
diffusive protein penetrating into the bead is zero. At the prop-
agation front, the incoming flux of protein is immediately con-
sumed to form the protein-ligand complex (Eqn. 6) according 
to Eqn. 14. 
F F
l
bead
F bead dl A L dt
r
P
A D
F
0 ] [*
] [



 (14a) 
F l
bead bead F
r
P
L
D
dt
dl



] [
] [* 0
   (14b) 
In this equation, r is the radial coordinate, AF is the cross-
sectional area of the front, lF is the radial position of the front, 
and dlF/dt is the velocity of the propagating front. We derive 
an estimate of the term ∂[P]bead/∂r by considering the region 
before the propagating front, where the incoming protein is 
subject only to diffusion. In this region, we can apply a pseu-
do-steady approximation to the concentration profile of diffus-
ing protein (Eqn. 15).  
0
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This approximation assumes that the concentration profile 
of diffusing protein is established much more rapidly than the 
propagating front moves (this approximation is reasonable 
when [P]0,solKbead/sol/[*L]0 << 1, as is the case in our system).
32 
We derive the average value <1/∂[P]bead/∂r|lF>r across the bead 
by solving Eqn. 15 using the following boundary conditions: 
at r = R, [P]bead = [P]0,solKbead/sol, and at r = lF, [P]bead = 0 (Eqn. 
16). 
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For our system, the characteristic time τ of the reaction-
diffusion process is proportional to the radius of the bead R 
over the average velocity of the propagating front, dlF/dt (Eqn. 
17).
32 Finally, combining Eqns. 14, 16, and 17 yields an ex-
pression that describes the characteristic time τ as a function of 
a number of experimental variables (Eqn. 18). 
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This expression indicates that the time required for the sys-
tem to reach steady-state is proportional to the square of the 
radius of the beads, R
2, the initial concentration of the ligands 
in the bead, [*L]0, and is inversely proportional to the diffu-
sion coefficient, Dbead, the initial concentration of protein in 
solution,  P0,sol and the partition coefficient, Kbead/sol. These 
mathematical relationships agree well with experiment (vide 
supra). In practice, the characteristic time τ can be derived 
from a plot of levitation height (h) versus time (t) by fitting the 
data to a first-order exponential equation (Eqn. 19), where hf 
and h0 are the final and initial levitation heights, respectively. 
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RESULTS AND DISCUSSION 
This section outlines a detailed physical-organic study of a 
MagLev-based analytical tool that can be used for (i) quantify-
ing the amount of protein bound to beads, and (ii) monitoring 
the kinetics and thermodynamics of association of proteins 
with resin-bound small molecules. We use this physical-
organic study to identify the parameters that ultimately influ-
ence the function and practicality of this tool. 
Unless specified otherwise, all MagLev measurements were 
performed in a solution of 300 mM Gd(DTPA), and 0.05% 
polysorbate 20, dissolved in 6-mM phosphate buffer and ad-
justed to pH 7.4 using sodium hydroxide (referred to through-
out this text as the ‘standard levitation buffer’). This composi-
tion provided a buffer with an approximate match in density to 
that of the PEGA beads. The chosen concentration of gadolin-
ium(III) provided a useful compromise between sensitivity and 
dynamic range of detection by MagLev.  Addition of the non-
denaturing surfactant, polysorbate 20, reduced non-specific 
binding of proteins to the PEGA beads, and prevented the 
beads from adhering to the cuvette.   
MagLev provides a spectroscopy-free method of measur-
ing the binding of protein to ligand-functionalized PEGA 
beads.  Initially, we verified that protein would adsorb to 
PEGA beads only when these beads were functionalized with 
a small-molecule ligand that bound specifically to that protein. 
We reasoned that the binding of most proteins (average densi-
ty ≈ 1.3–1.5 g·cm
-3) to PEGA beads (density ≈ 1.07 g·cm
-3) 
should increase the density of the beads, and result in quantifi-
able changes in levitation height between bound and unbound 
states. 
Throughout these studies, we used a well-characterized sys-
tem of proteins and ligands: bovine carbonic anhydrase (BCA) 
and derivatives of benzenesulfonamide.
16 We immobilized 4-
carboxybenzene sulfonamides 1  and  2  on Rhodamine-dyed 
PEGA beads using standard coupling chemistry (Eqn. 20, 
EDC = N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide, 
NHS = N-hydroxysuccinimide; see Supporting Information for 
more information). 6 
 
 
Sulfonamide  1, when bound to resin, is expected to bind 
tightly to BCA (the Kd of an analogous ligand in solution is 0.7 
μM, see Supporting Information). Sulfonamide 2 should not 
associate measurably with BCA;
16 this functionalized bead 
serves as a control. The PEGA beads we used have a density 
of amine groups of 0.2 mmol·g
-1 (when dry); this value gives a 
final concentration of ligand within the bead of 1 – 10 mM 
(when swollen in water). 
 
Figure 3.  Monitoring the association of bovine carbonic anhy-
drase (BCA) with 4-carboxybenzene sulfonamide (1) immobi-
lized on PEGA beads. We levitated functionalized PEGA beads in 
cuvettes in the standard levitation buffer.  (A) Adding BCA to the 
levitation media resulted in a change in levitation height (h) that 
depended on time, and on the concentration of protein. The figure 
shows the fit of the experimental plots to the estimates from the 
reaction-diffusion model. The reaction-diffusion model predicts 
that the time to reach equilibrium should be proportional to the 
protein concentration (equilibration is predicted be faster with 
higher protein concentrations). (B) We illustrate the effect of the 
ligand concentration within the bead on the rate of change in levi-
tation height. The data confirm that the time to reach equilibrium 
is inversely proportional to the ligand concentration, as predicted 
by the reaction-diffusion model. 
At least one hour before each experiment, the PEGA beads 
were placed in a solution of the standard levitation buffer in 
order to insure that they equilibrated completely with this 
buffer. We then transferred seven to ten beads functionalized 
with either sulfonamide 1 or 2 into a microcuvette containing 
0.6 mL of a solution of BCA in the standard levitation buffer. 
We observed only a very small decrease (< 0.1 mm) in the 
levitation height of beads functionalized with 4-
dimethylsulfamoylbenzoic acid  2 after incubation with 0.33 
mM BCA for 7 days. In contrast, we observed a time- and 
concentration-dependent change in the levitation height of 
beads functionalized with sulfonamide 1. 
We plotted the change in levitation height of beads func-
tionalized with sulfonamide 1 (Δh, in millimeters) versus time 
(t, in hours) for each concentration of BCA and fit these data 
to our model of the reaction-diffusion process (Eqns. 7, 8). 
The comparison demonstrates good agreement (Figure 3A). 
We estimate the dissociation constant from the model to be Kd 
~ 1.5 μM. We note that since the process of protein binding to 
ligands within the beads is diffusion-limited (see the Section 
on characteristic time for further discussion), we can only de-
termine Kd, and not the on and off rates (koff  and kon). 
Eqn. 21 presents an alternative method of calculating the 
dissociation constant using the equilibrium conditions of the 
reaction summarized in Eqn. 6, and assuming that protein is in 
excess.  
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Experimentally we found that with [P]0,sol = 100 μM, [*L]0 = 
3.2 mM and Kbead/sol = 0.4, the final change in height of the 
beads is 26.5 mm; this value indicates that the [*PL]eq is 3.08 
mM (Eqn. 4). Substituting these values into Eqn. 21 gives a 
dissociation constant, Kd, of 1.5 μM. 
These results demonstrate that this MagLev-based method 
provides reasonable estimates of binding constants for BCA 
with benzenesulfonamides, without the need for spectroscopy. 
The small difference between the measurements using Mag-
Lev and more conventional spectroscopic means may be due 
to an increase in the protein-ligand dissociation constant as a 
result of immobilization of the ligand. We previously found 
that the observed dissociation constants of BCA with ligands 
in solution are ~ 10 times lower than the dissociation constants 
of the corresponding ligands presented on the surface of a 
monolayer.
33 
The system reaches a state of equilibrium more rapidly 
when higher concentrations of protein in solution and/or 
lower concentrations of ligand within the beads are used. 
Based on our derivation of the characteristic time, τ, we hy-
pothesized that both increasing the concentration of protein in 
solution, and decreasing the concentration of ligand within the 
bead, should increase the rate at which the bead would reach 
an equilibrium concentration of protein and protein-ligand 
complex ( sol P L , 0 0 ] /[ ] [ ~  , Eqn. 18). In addition to decreasing 
the assay time, experimenting with these parameters would 
also allow us to test the validity of our model. To vary the 
concentration of ligand within the beads, we combined ben-
zene sulfonamides 1 and 2 in molar ratios of 1:0, 1:2, 1:8, 
1:26, and 1:80. We used these mixtures to synthesize batches 
of PEGA beads containing different concentrations (3.2 – 
0.040 mM) of benzene sulfonamide (Eqn. 22). 7 
 
 
We placed 7 – 10 of each batch of beads in a microcuvette 
containing a solution of 100 μM bovine carbonic anhydrase 
(BCA) dissolved in the standard levitation buffer and plotted 
the change in levitation height (Δh, in millimeters) versus time 
(t, in hours) for each concentration of ligand (Figure 3B). Fit-
ting these data to our reaction-diffusion numerical integration 
model (Eqns. 3, 10) revealed the expected correlations: lower 
concentrations of ligand within the bead resulted in smaller 
changes in levitation height (Δh = h0 - hf); the equilibration 
time was, however, inversely proportional to the concentration 
of ligand in the bead. 
 
Figure 4.  Effect of the concentration of protein in solution, and 
the ligand concentration within the beads, on rates of equilibra-
tion. We calculated each characteristic time, τ, by fitting a plot of 
levitation height versus time to Eqn. 18. The combined data sub-
stantiate our derivation of the characteristic time (Eqn. 17) by 
illustrating the predicted linear relationships between (A) the 
characteristic time τ and the concentration of ligand within the 
bead (expressed as the percentage of the bead functionalized with 
sulfonamide 1), and (B) the characteristic time τ and one over the 
concentration of protein in solution (1/[BCA]0,sol). 
In order to verify these results further, we repeated the same 
experiment with several different concentrations of BCA. Each 
plot was fit to a first-order exponential curve (Eqn. 19) from 
which we derived the calculated characteristic times τ. Figure 
4 illustrates the expected mathematical relationships. In Figure 
4A, we plot characteristic time against the concentration of 
ligand 1 within the bead (τ versus [*1]bead); the data demon-
strate the expected linear relationship, with the exception of 
the datum at 100% concentration of sulfonamide 1 and 10-μM 
protein.
34  Similarly, Figure 4B reveals the linear relationship 
between the characteristic time and the inverse of the concen-
tration of protein in solution, (1/[BCA]0,sol; again with exclu-
sion of the datum at 100% concentration of 1 and 10-μM pro-
tein). Thus, equilibration is much faster with lower concentra-
tions of ligand within the bead ([*L]0), and with higher con-
centrations of protein in solution ([P]0,sol), as predicted by both 
the reaction-diffusion model and our derivation of the charac-
teristic time τ (Eqns. 10, 18). 
 
Figure 5. Effect of the radius of the bead on the rate of binding of 
BCA to ligand-functionalized beads. We levitated functionalized 
PEGA beads in cuvettes in the presence of 130 μM BCA dis-
solved in the standard levitation buffer. We plot the average levi-
tation height for eight large beads (<R> = 166 ± 5 μm), and eight 
small beads (<R> = 136 ± 7 μm) versus time, and show the pre-
dictions of the reaction diffusion model (the dotted and dashed 
lines). 
The rate of equilibration is faster for smaller beads. 
PEGA beads, as supplied commercially, span a range of sizes. 
For our studies, beads purchased from Polymer Laboratories 
were reported to range in diameter from 300 – 500 microns 
(when swollen in water). To quantify the effect of bead size on 
the rate of binding of protein to ligands within the bead, we 
isolated the largest and smallest beads by filtering through 
several sizes of mesh (see Supporting Information).  
We levitated eight large beads (average radius of 166 ± 5 
microns) and eight small beads (average radius of 136 ± 7 
microns) in a solution of 130-μM BCA dissolved in the stand-
ard levitation buffer. Figure 5 shows the comparison of the 
change in levitation height (Δh, in millimeters) versus time (t, 
in hours) for each batch of beads. When these data were fit to 
first-order exponential curves (Eqn. 19), the calculated charac-
teristic times, τ, were 14.6 ± 2.7 hours for the small beads, and 
26.9 ± 2.1 hours for the large beads. This ratio is in accord 
with our prediction of the relationship between the radius of 
the bead (R) and τ (τ ~ R
2, Eqn. 18). 
MagLev enables multiple binding interactions to be 
monitored simultaneously. MagLev provides the basis for an 
on-bead assay that can measure the affinity of multiple differ-
ent resin-bound small molecules for the same protein. To make 
it possible to differentiate resin-bound inhibitors visually, we 
functionalized a small portion of the available amines on 
PEGA beads with one of five different dyes (isothiocyanates 
of rhodamine, fluorescein, malachite green, eosin and 7-
dimethylamino-4-methylcoumarin).  Using standard coupling 
chemistry, we attached five different ligands (4-8 
 
carboxybenzene sulfonamide, 4-(isothiocyanatomethyl) ben-
zenesulfonamide 3-carboxybenzene sulfonamide, 3-carboxy-4-
methoxybenzene sulfonamide, and 4-
dimethylsulfamoylbenzoic acid) of carbonic anhydrase to the 
differently colored beads. 
We then suspended these five color-coded beads, each func-
tionalized with a different inhibitor of BCA, (~15 beads per 
inhibitor) in a microcuvette containing a solution of 100-µM 
BCA dissolved in the standard levitation buffer. Initially, the 
beads all levitate at nearly the same height (Figure 6).
35  In the 
presence of BCA, the beads begin to sink, and begin to segre-
gate based on binding affinities. The relative levitation height 
of the beads represents the relative differences in binding af-
finities of the ligands attached to the beads; the bead contain-
ing the ligand with the lowest dissociation constant for BCA 
levitates at the lowest value of h because it has more protein 
bound to it than the other two beads. Using Eqn. 21, we calcu-
lated the dissociation constants  of the immobilized ligands 
from BCA. We also measured the dissociation constants of 
analogous ligands in solution using fluorescence (see Support-
ing Information). A comparison of the values measured using 
both methods demonstrates good agreement (Figure 6). 
At the beginning of the experiment, the beads form relative-
ly tight clusters because they have equal densities. As the 
beads approach 50% equilibration, however, they become 
increasingly disperse. We hypothesize that this dispersion 
results from differences in the percentage of ligands that are 
bound to protein as a result of differences in the size of the 
beads.
6b As the beads approach their final levitation height, 
their dispersion in levitation heights decreases because each 
bead contains the same concentration of ligand, and the final 
equilibrium levitation height ultimately depends only on the 
density of the bead, not on its radius. 
 
Figure 6.  Using MagLev to measure the binding of BCA to sev-
eral immobilized ligands. This figure presents a series of photo-
graphs showing changes in levitation height over time that result 
from incubating PEGA beads functionalized with five different 
inhibitors of BCA in the presence of 100 µM BCA dissolved in 
the standard levitation buffer.  We used Eqn. 21 to calculate the 
dissociation constants of the immobilized ligands from BCA; also 
shown, in parentheses, are the dissociation constants of analogous 
ligands in solution from BCA (see Supporting Information). 
MagLev is a useful tool for quantifying the concentra-
tion of a specific protein. Methods for the detection of small 
amounts (nmol – fmol) of protein have revolutionized biotech-
nology, and comprise some of the most heavily used methods 
for the diagnosis of disease.
36 In order to adapt the MagLev-
based methods described in this paper to the detection of small 
amounts of protein, we utilize a semi-kinetic approach. We 
begin by incubating a single bead in a solution of a target pro-
tein. To provide optimal detection of small amounts of protein, 
we fully functionalize this bead with a ligand that binds tightly 
to the target protein. Specifically, we use PEGA beads func-
tionalized with sulfonamide 1 to detect BCA. 
With the goal of detecting low concentrations of protein, it 
is beneficial to maximize the sensitivity of the system to 
changes in the density of the bead by performing measure-
ments of levitation height using the lowest practical concentra-
tion of paramagnetic salt. For these measurements, we, there-
fore, utilize a lower concentration of Gd(DTPA) than what is 
present in the standard levitation buffer: 150 mM Gd(DTPA) 
provides a practical compromise between sensitivity and equi-
libration time.  With this concentration of Gd(DTPA), the 
beads reach their equilibrium levitation height in ~ 30 minutes 
and we are able to differentiate between differences in density 
of ± 0.0004 g·cm
-3. With lower concentrations of Gd(DTPA) 
sensitivity is increased, but the beads take significantly longer 
to reach their equilibrium levitation height.
6c Future studies 
will focus on increasing the rate of adsorption of protein by 
using smaller beads, lower concentrations of ligand within the 
beads, or beads with larger pore volumes. 
Reaching an equilibrium state at low concentrations of pro-
tein requires an impractically long time (for example, a bead 
functionalized with sulfonamide 1 requires more than a thou-
sand hours to equilibrate fully with a 10-μM solution of BCA). 
A calibration curve, however, can easily be generated to relate 
the change in levitation height after a given period of time to 
the concentration of protein in the sample. Figure 7 demon-
strates this relationship.
37 
To generate the data in Figure 7A, we incubated individual 
beads, functionalized with sulfonamide 1, in solutions (20 μL) 
of BCA (40 nM – 40 μM) dissolved in 10 mM PBS at room 
temperature (20 °C), for either 3 or 24 hours. We then trans-
ferred these beads into a microcuvette containing a solution of 
150 mM Gd(DTPA) and 200 mM sucrose dissolved in 6 mM 
phosphate buffer and adjusted to pH 7.4 with NaOH (referred 
to hereafter as the ‘high sensitivity levitation buffer’), and 
measured their levitation height (in comparison to the levita-
tion height of a bead that had been incubated in a solution free 
of BCA). After three hours, beads that have been incubated in 
a 600 nM solution of BCA can be distinguished from beads 
that have been incubated in a solution free of BCA; after 24 
hours the detection limit is lowered to 300 nM. Notably, this 
method requires only 20 μL of sample (the volume of blood in 
a typical finger prick). 
The initial rate of protein absorption correlates linearly with 
the concentration of protein in solution (τ ~ 1/[P]0,sol, Eqn. 18); 
as the ligands become saturated with protein, however, the rate 
of net protein diffusion into the beads decreases. The result is 
that at short incubation times, there is an approximately linear 
relationship between the concentration of protein in the incu-
bation solution and the amount of protein adsorbed on the 
bead, while at longer incubation times this simple correlation 
no longer holds true (at very long incubation times the system 9 
 
approaches equilibrium, where binding is described by Eqn. 
21). 
 
Figure 7. Detecting BCA using MagLev. For these experiments, 
beads were levitated in the high sensitivity levitation buffer. (A) 
We incubated individual beads, functionalized with sulfonamide 
1, in solutions (20 μL) of BCA (40 nM – 40 μM) dissolved in 1 x 
PBS at room temperature (20 °C), for either 3 or 24 hours. After 
incubation, we transferred the beads into microcuvettes contain-
ing the high-sensitivity levitation buffer, and measured their levi-
tation heights (in comparison to a bead that had been incubated in 
a solution free of BCA). We then repeated this experiment, 
changing the incubation media to whole blood (the beads were 
filtered and washed before levitation). The error bars show one 
standard deviation (n = 7). (B) We examined the temperature 
dependence of the protein detection process. Over a 24 hour peri-
od, beads that were incubated at 5 °C absorbed slightly less pro-
tein than beads that were incubated at 40 °C. 
MagLev can be used to detect BCA in blood. This short 
study was intended to determine if MagLev could operate suc-
cessfully starting with samples as complex as blood and se-
rum. We incubated individual beads, functionalized with sul-
fonamide 1, in 20 μL aliquots of whole blood containing 2-
fold dilutions of BCA (40 nM – 40 μM). After 3 hours we 
separated these beads from the blood by filtration through a 
fine mesh and rinsed them with levitation buffer. We then 
transferred the beads into a microcuvette containing the high 
sensitivity levitation buffer (described above), and measured 
their levitation heights (in comparison to the levitation height 
of a bead that had been incubated in whole blood containing 
no added BCA; Figure 7A). These results indicate that this 
method is capable of detecting a specific protein in a complex 
biological medium such as blood without the need for initial 
separation or purification steps. 
The temperature of incubation has only a small influ-
ence on the reaction-diffusion process. We also examined 
the temperature dependence of this method of detecting pro-
tein (Figure 7B). We incubated PEGA beads, functionalized 
with sulfonamide 1, in solutions of BCA (40 nM – 40 μM) at 
two different temperatures (5 °C, 40 °C) for 24 hours. We 
observed that only slightly more protein was absorbed into the 
beads that were incubated at the warmer temperature. The 
difference between the levitation heights of the beads that 
were incubated at these two temperatures is predicted by the 
inverse relationship between the characteristic time, τ, of the 
reaction-diffusion process and the diffusion coefficient of the 
protein within the bead ( bead D / 1 ~  , Eqn. 18). The depend-
ence of the diffusion coefficient, D, on temperature, T, can be 
approximated by the Stokes–Einstein equation (Eqn. 23), 
where kB is Boltzmann’s constant, η is the dynamic viscosity of 
the levitation media inside the bead, and R is the hydrodynam-
ic radius of the protein inside the bead. We assume that the 
levitation media has a dynamic viscosity similar to that of wa-
ter (η5°C = 1.519, η40°C = 0.653), and that R is independent of 
temperature; the ratio of Dbead,40°C and Dbead,5°C is, therefore, ~ 
2.1. This value agrees qualitatively with the increased rate of 
the reaction-diffusion process at higher temperatures. 
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CONCLUSION 
MagLev provides a new way to detect and measure specific 
protein-ligand interactions. Its simplicity and independence of 
electricity and infrastructure suggest that, with development, it 
has the potential to be useful in resource-limited environments. 
In this method, the binding of protein to ligands immobilized 
within a gel bead results in a change in the density of the bead. 
MagLev allows the density of the bead to be monitored in real 
time with high accuracy, and therefore provides a direct 
readout of the amount of protein bound to the bead. 
We have developed a mathematical model of the reaction-
diffusion processes that result in the binding of protein to lig-
ands immobilized within the bead. This model provides good 
quantitative agreement between theory and experiment. The 
magnitude of the change in levitation height as a function of 
time depends on a number of controllable parameters includ-
ing: (i) the concentration of protein in solution, (ii) the struc-
ture, concentration, and binding constant of the ligand immo-
bilized in the bead, and (iii) the size of the bead. The rate of 
change in levitation height also depends on a number of fac-
tors that are more difficult to manipulate, such as: (i) the parti-
tion coefficient of the protein between the bead and the bulk 
solution, and (ii) the diffusion coefficient of protein within the 
bead. We developed Eqn. 17, which describes the dependence 
of the characteristic time, τ, for protein binding to ligands im-
mobilized within gel beads, on all of the reaction parameters. 
This equation, therefore, allows the performance of the system 
to be predicted, under a variety of conditions.  
Overall, the MagLev-based method for detecting protein-
ligand binding has a number of significant advantages: (i) This 
method requires no electricity, and only a single piece of 
equipment. It may, therefore, find use in situations where port-
ability and low cost are a high priority; for example, in point-
of-care diagnosis, especially in resource-limited, military, and 
point-of-care environments, or in veterinary medicine, plant 
pathology, and food safety. (ii) It is easy to use; results can be 
visualized with the naked eye. (iii) It has the capability to 
monitor binding accurately in real time. This attribute provides 
a quantitative means of determining the concentration of a 10 
 
specific protein in solution. (iv) It can qualitatively distinguish 
the binding affinities of a protein to several resin-bound small 
molecules simultaneously. In analogy, MagLev should also be 
capable of simultaneously measuring the binding of multiple 
proteins to an array of resin-bound small molecules. This 
property should allow for the ready design of multiplexed 
binding assays. (v) Protein-ligand binding directly results in a 
change in levitation height. This method, therefore, does not 
require intermediate reagents, such as enzyme-linked second-
ary antibodies.  
In its present form, this method also has several disad-
vantages, but there are clear development paths to reduce or 
eliminate these issues. These disadvantages include: (i) The 
kinetics of protein-ligand binding are relatively slow (on the 
order of several days). This problem may potentially be re-
solved through the design and synthesis of beads with im-
proved characteristics (e.g., larger pore size). (ii) This method 
is only applicable to ligands that are amenable to chemical 
immobilization on a gel support; this limitation, however, is 
inherent to most detection methods that occur on solid support. 
(iii) This method is currently not applicable to large proteins, 
most notably antibodies, due to the restricted pore size of 
PEGA beads. 
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